According to the Food and Drug Administration (FDA), Cantrell Drug Company has recalled almost 30 lots of various sterile drug products because of a concern over their actual sterility. The products were distributed across the country to various healthcare facilities from May 25 to October 31, 2016.
Some of the products contained calcium chloride, fentanyl citrate, glycopyrrolate, heparin sodium, hydromorphone, midazolam, lidocaine, neostigmine, oxytocin, morphine sulfate, phenylephrine, rocuronium bromide, succinylcholine, and ropivacaine. If these drugs are administered when they are not 100% sterile, the treatment could result in serious infections that could be life-threatening. A full list of the products included in this recall is contained in the press release posted by the FDA on their website here.
So far, the company, based in Little Rock, Arkansas, hasn’t received any reports of adverse events, but it is issuing the recall out of caution following a recent inspection of the company’s facility. Clinicians and others who have the products have been warned to stop using them and contact the company. Cantrell is also notifying its customers by email and telephone and is arranging for a full return of all product.
In a statement about the lack of sterility, the CEO of Cantrell said the company is thoroughly committed to quality and safety. If you need to return medication or require help related to this recall, contact Cantrell at (877) 666-5222 during their regular business hours.
If you or a loved one have been injured by a defective drug or medical product, talk to one of our experienced San Francisco defective pharmaceutical attorneys at Kaiser Gornick LLP. Our firm has the knowledge and resources to handle all personal injury claims effectively, and we are proud to offer personalized attention to each client. We have more than 50 years of combined legal experience to offer your case. Let us see what we can do for you and your family.
Contact us at or fill out our online form to schedule a free initial consultation with us today.